Latest Breaking News On - Livanova united states - Page 2 : comparemela.com

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

LivaNova PLC , a market-leading medical technology company, today reported results for the quarter and full year ended December 31, 2023 and issued guidance for 2024. Financial Summary and.

LivaNova to lay off 137 in Pennsylvania

LivaNova (Nasdaq: LIVN) plans to lay off 137 employees at its Pittsburgh, Pennsylvania location by the end of this year.

LivaNova Reports Third-Quarter 2023 Results

Esketamine Bests Quetiapine for Resistant Depression

Intranasal esketamine (Spravato, Janssen) is superior to extended-release quetiapine (Seroquel, AstraZeneca) for treatment-resistant depression, results of a multicenter, head-to-head phase 3 trial show.

Cadence Neuroscience raises $26M for epilepsy neuromod therapy

Neurmodulation technology developer Cadence Neuroscience announced that it secured $26 million in a Series B financing round.